Cheapest Compounded Semaglutide and Tirzepatide in 2026: Price Comparison Guide
What you'll actually pay for compounded GLP-1 medications in 2026 — with the hidden costs most provider websites don't show upfront.
Compounded semaglutide and tirzepatide remain the most affordable entry point for GLP-1 treatment in 2026, but the market has shifted significantly since the FDA resolved the semaglutide shortage in early 2025. Prices, availability, and regulatory requirements have all changed — and the cheapest advertised price rarely tells the full story.
This guide breaks down what compounded GLP-1 medications actually cost in 2026, which providers offer genuine all-in pricing, and how to avoid common pricing traps that inflate your monthly bill.
Key Takeaways
- Compounded semaglutide ranges from $99–$500/month depending on provider, dose, and what's included
- Compounded tirzepatide starts around $149–$399/month — typically more expensive than semaglutide
- The cheapest headline price often excludes provider visits, shipping, supplies, or membership fees
- Post-shortage FDA rules require documented medical need for compounded semaglutide
- Always verify your provider uses a licensed, accredited compounding pharmacy (PCAB or 503B registration)
Compounded Semaglutide Pricing in 2026
Compounded semaglutide previously cost around $149–$299 per month at most telehealth providers. After the FDA ended the national semaglutide shortage in February 2025 and tightened compounding rules through April 2026, the market shifted: some providers raised prices, others left the market entirely, and a new group of budget-focused platforms entered with aggressive pricing.
Here's what the pricing landscape looks like right now:
| Price Tier | Monthly Range | Typically Includes | Watch For |
|---|---|---|---|
| Budget | $99–$169 | Medication only; basic async consult | Separate membership fees, limited support, dose-based price increases |
| Mid-Range | $170–$299 | Medication + provider visits + shipping | Dose escalation surcharges at higher doses ($399–$499 at maintenance) |
| Premium | $300–$500 | All-inclusive: meds, visits, coaching, labs, supplies | Paying for extras you may not need or use |
Compounded Tirzepatide Pricing in 2026
Compounded tirzepatide is generally more expensive than compounded semaglutide because the raw ingredient costs more to source and compound. Availability also varies — not every provider that offers compounded semaglutide also offers tirzepatide.
Typical compounded tirzepatide pricing in April 2026:
- Starter doses (2.5–5 mg): $149–$299/month at most providers
- Mid-range doses (7.5–10 mg): $299–$399/month
- Maintenance doses (12.5–15 mg): $399–$500+ /month
If you're comparing compounded tirzepatide against Eli Lilly's LillyDirect cash-pay program (Zepbound single-dose vials at $499/month flat rate for any dose), the math gets interesting at higher doses — LillyDirect becomes competitive or even cheaper once you reach maintenance dosing, with the added benefit of being an FDA-approved product.
If cost is your primary driver, compounded semaglutide is almost always cheaper than compounded tirzepatide. Clinical trials have shown tirzepatide produces slightly more weight loss on average (SURMOUNT-5 data), but both medications are highly effective. The cost difference of $50–$200/month over 6–12 months adds up. Discuss with your provider which makes sense for your goals and budget.
The Hidden Cost Problem
The biggest pricing challenge in the compounded GLP-1 market isn't the medication cost itself — it's the gap between the advertised price and your actual monthly spend. Here are the most common hidden costs to ask about before signing up:
Membership or Platform Fees
Some providers charge a separate monthly membership fee ($49–$99/month) on top of medication costs. A "$99/month medication" with a $79 membership is actually $178/month. Always ask if there's a membership or subscription fee.
Dose-Based Price Increases
Many providers advertise their lowest dose price as the headline number. As you titrate up to effective maintenance doses, prices can increase significantly — sometimes doubling. Ask what the price is at your expected maintenance dose, not just the starter dose.
Provider Visit Fees
Initial consultations may be free, but some providers charge $50–$100 for follow-up visits, dose adjustments, or lab reviews. Clarify whether ongoing provider access is included in your monthly cost.
Shipping and Supplies
Injectable compounded medications require syringes, alcohol swabs, and cold-chain shipping. Some providers include everything; others charge $15–$30 per shipment. This can add $30–$60/month in costs that don't appear in the advertised price.
Be cautious of providers advertising compounded semaglutide significantly below $99/month. At that price point, it's worth verifying the pharmacy's licensing status, the formulation details, and whether the provider includes any clinical oversight. Quality compounding has real costs, and extreme low pricing can indicate corners are being cut.
What Changed After the FDA Shortage Resolution
The FDA confirmed the semaglutide injection shortage was resolved in February 2025. This triggered enforcement timelines for compounding pharmacies that had been producing semaglutide under the shortage exemption. 503A pharmacies faced an April 22, 2025 deadline; 503B outsourcing facilities had until May 22, 2025.
In April 2026, the FDA issued further guidance clarifying what constitutes an "essentially a copy" of a commercially available product — further narrowing the conditions under which compounding pharmacies can produce semaglutide formulations.
The practical impact: compounded semaglutide is still available, but only for patients with documented medical needs that can't be met by FDA-approved products (such as specific dosing requirements, allergies to inactive ingredients, or need for alternative delivery formats). Your provider should be able to explain why compounded medication is appropriate for your specific situation.
How to Find a Safe, Affordable Provider
When evaluating compounded GLP-1 providers, price should be one factor — not the only factor. Here's a quality checklist:
Pharmacy credentials matter. Your medication should come from a licensed 503A or 503B compounding pharmacy. Ideally, look for PCAB (Pharmacy Compounding Accreditation Board) accreditation, which indicates the pharmacy meets additional quality standards beyond baseline licensing.
Provider oversight should be real. A licensed prescriber should evaluate your medical history, review any relevant lab work, and monitor you during treatment. Fully automated systems with no human clinical review are a red flag.
Transparency about formulation. You should know exactly what's in your medication: the active ingredient concentration, the formulation type (injectable, sublingual, oral dissolving tablet), and any additional compounds. Ask if third-party potency and sterility testing is performed.
Clear refund and cancellation policies. Understand what happens if you're not approved for treatment, if you experience side effects that require stopping, or if you simply want to cancel. Reputable providers offer refunds for unapproved prescriptions and flexible cancellation.
Compare Verified GLP-1 Providers
See real all-in pricing, pharmacy accreditation status, and patient ratings for compounded semaglutide and tirzepatide providers.
Compare Providers →Paid link · We may earn a commission if you sign up through our links
Compounded vs. Brand-Name: When Each Makes Sense
Choose compounded if you need lower cost and don't have insurance coverage, if you need custom dosing flexibility, if you prefer alternative formats (sublingual, oral dissolving tablets), or if you have allergies to inactive ingredients in brand-name products.
Choose brand-name if you have insurance that covers it (your cost may actually be lower), if you prefer the convenience of pre-filled pens, if you want FDA-approved manufacturing consistency, or if you're concerned about the regulatory uncertainty of compounded products.
Neither option is inherently better. The right choice depends on your medical needs, financial situation, and comfort level with each pathway.